Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-210-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50(oral) = 2232 mg/kg b.w
LC0(inhalation) = 2.10 mg/l
LD0(dermal) = 2700 mg/kg b.w
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Value:
- 2 232 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 21, 1978 to May 5, 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study
- Principles of method if other than guideline:
- 4-Hour Acute Inhalation Toxicity in Rats in Accordance With the Regulations as Defined in the Protocol Submitted by Ciba-Geigy. Ten laboratory rats (5 males & 5 females) are exposed in a 40 liters (36 x 36 x 31 cm) glass exposure chamber, to the test substance via the inhalation route at an atmospheric concentration of 2.34 ± 0.26 mg/l for 4 hours.
- GLP compliance:
- no
- Test type:
- fixed concentration procedure
- Species:
- rat
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: no data- Weight at study initiation: 245 - 324 g- Housing: The animals were housed, individually, in suspended wire bottom cages- Diet: ad libitum- Water: ad libitumENVIRONMENTAL CONDITIONS- Temperature (°C): 23 ± 1 °C- Humidity (%): 45-55 %- Photoperiod (hrs dark / hrs light): 12 hours cycle dark/light
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTIONThis test was conducted in a 40 l (36 x 36 x 31 cm) glass exposure chamber. The sides and the bottom of the chamber had centred holes (3-4 cm in diameter) to allow access to the chamber for testing and exhaust of the atmosphere. The port in the bottom of the chamber was centred over a 10 cm hole in a wooden platform. A funnel (8.5 cm in diameter) was brought from the underside of the platform through the hole and centred on the port in the bottom of the chamber. Dynamic air flow within the chamber was maintained by connecting the funnel to a vacuum pump for continuous changing of the chamber atmosphere.- Exposure chamber volume: 40 l (36 x 36 x 31 cm) glass exposure chamber.- Source and rate of air: Dynamic air flow within the chamber was maintained by connecting the funnel to a vacuum pump for continuous changing of the chamber atmosphere.- System of generating particulates/aerosols: The test substance was generated as a dust using a 3-neck, round-bottom, 250 ml Pyrex flask. A stirring mechanism was placed through the center neck of the flask and an air line through one of the side necks. The third neck was connected by a glass elbow (which had an air vent to allow flushing) to the chamber. The dust was introduced into the chamber through a side port. A piece of rubber was taped over the outer area around the hole and a vertical slit made in the rubber to allow the entrance of the glass elbow from the dust generator. Constant flow of material was maintained by a calibrated flowmeter connected between the air line and the generating apparatus. In all instances, the air flow was maintained at or above 0.5 liter of air per minute per rat. - Method of particle size determination: Particle size determinations were made using a Cascade Impactor- Treatment of exhaust air: filter holder was attached to a vacuum pump which was regulated to exhaust 1.0 liter of air per minute from the chamber through the filterTEST ATMOSPHERE- Brief description of analytical method used: Measurement of the atmospheric concentration of test substance in the chamber was achieved using a Gelman Model 1235 stainless steel filter holder containing a pre-weighed glass fiber filter (Gelman type AE-47 mm).
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- ca. 4 h
- Concentrations:
- 2.34 ± 0.26 mg/l
- No. of animals per sex per dose:
- 5 per sex per dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days- Frequency of observations and weighing: 4 times for clinical signs. All animals were weighed prior to the initiation of the exposure and on days 1, 7 and 14 following exposure. - Necropsy of survivors performed: yes- Other examinations performed: clinical signs, body weight, organ weights, histopathology
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- ca. 2.34 mg/L air (analytical)
- Based on:
- test mat.
- 95% CL:
- ca. 0.26
- Exp. duration:
- 4 h
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC0
- Effect level:
- ca. 2.106 mg/L air (analytical)
- Based on:
- act. ingr.
- 95% CL:
- ca. 0.26
- Exp. duration:
- 4 h
- Mortality:
- no mortality observed
- Clinical signs:
- other: abnormal respiration was noted during the first 2 hours post-exposure. This condition was not noted 4 hours post-exposure and animals appeared normal for the remainder of the observation period.
- Body weight:
- Eight animals (4 males and 4 females) showed slight weight losses on day one; however, all animals were gaining weight normally for the remainder of the observation period.
- Gross pathology:
- The results of the gross pathological examinations showed that organs of all rats were within normal limits.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- not classified according to CLP Regulation (EC n. 1272/2008)
- Conclusions:
- The test substance shows no adverse effect at concentration of 2.34 mg/l (2.10 mg/l based on active ingredient).
- Executive summary:
The substance has been tested for acute toxicity via inhalation route. Ten laboratory rats (5 males and 5 females) initially weighing between 245 and 324 grams, when exposed to test substance via the inhalation route at an atmospheric concentration of 2.34 ± 0.26 mg/l for 4 hours, exhibited no observable adverse clinical signs during the exposure. Abnormal respiration was observed in all animals during the first 2 hours post-exposure. However, all animals appeared normal when observed 4 hours after the exposure. No abnormalities were noted during the 14-day post-exposure period, therefore the LC0 is 2.34 mg/l (2.10 mg/l based on active ingredient). The concentration stated above was the maximum attainable aerosol concentration of the test material under the experimental conditions. The average mass median particle diameter was 8.04 ± 1.62 µm. Gross pathological observations showed organs of all animals to be within normal limits.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Value:
- 2 106 mg/m³
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From April 17, 1978 to May 1, 1978
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 434 (Acute Dermal Toxicity - Fixed Dose Procedure)
- Deviations:
- not specified
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: Ace Animals, Boyertown, Pennsylvania- Weight at study initiation: 2.0 and 3.1 kgThe animals were fed, housed and maintained in accordance with standard laboratory procedures
- Type of coverage:
- open
- Vehicle:
- not specified
- Details on dermal exposure:
- TEST SITE- % coverage: 30 % of each animal's skin surfaceREMOVAL OF TEST SUBSTANCE- Washing (if done): yes , with warm water- Time after start of exposure: 24 hours after the star
- Duration of exposure:
- 24 hours
- Doses:
- 3000 mg/kg bw
- No. of animals per sex per dose:
- 3 per sex per dose
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Duration of observation period following administration: 14 days - Frequency of observations and weighing: daily- Necropsy of survivors performed: yes
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- ca. 3 000 mg/kg bw
- Based on:
- test mat.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- ca. 2 700 mg/kg bw
- Based on:
- act. ingr.
- Clinical signs:
- There were no adverse clinical signs observed in any of the six animals throughout the study
- Body weight:
- Individual body weight fluctuations presented no consistent pattern of significance.
- Gross pathology:
- Necropsies revealed all organs to be within normal limits.
- Interpretation of results:
- GHS criteria not met
- Remarks:
- not classified according to CLP Regulation (EC n. 1272/2008)
- Conclusions:
- The test substance at a dose level of 3000 mg/kg bw, produced oedema and erythema up to day 6, but no mortality, therefore the LD0 = 3000 mg/kg bw (2700 mg/kg b.w based on active ingredient)
- Executive summary:
New Zealand albino rabbits, when exposed dermally to the test substance at a dose level of 3000 mg/kg bw, corresponding to 2700 mg/kg bw based on active ingredient, produced oedema and erythema up to day 6, but no mortality. All gross necropsies were within normal limits. Within 7 days of observation period all animals were normal and remained so throughout the study.
Reference
All animals exhibited erythema and edema on day one. On day 2, two animals showed oedema and two animals showed erythema. On the 3rd day of scoring, two animals displayed oedema and one animal displayed erythema. This lasted until day four. On day 5 and 6, one animal showed oedema and one animal showed erythema. By day 7, all animals were normal and remained so throughout the study.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 700 mg/kg bw
Additional information
Acute oral toxicity:
The key study made in 1974 was conducted with similar substance 1 and its concentration is 72 % . The substance shows no mortality at any concentrations and the signs of toxicity were: sedation, dyspnoea, exophthalmos, curved position and ruffled fur. These symptoms become more accentuated with the dose increased. The calculated LD50 is more than 2232 mg/kg b.w. based on active ingredient.
The supporting study made in 1990 was a short abstract, but the purity of the substance was 85 %, the composition of the tested batch is known and the curve dose/response was good described. The substance shows an LD50 = 7380.55 mg/kg b.w. No information about methods and signs of toxicity.
In the study conducted on 1973, the substance shows slight signs of toxicity by oral route, LD50 = 1837.5 mg/kg bw based on active ingredient. The rats show the following signs: ditto, ataxia, hypoventilation. The purity of the test substance is around 75 %, no data is specified by the customer about 25% of the test product. The 25 % of the substance could influence the toxicity of the experiment, therefore this is the main reason for disregarding the study.
The key study and the supporting study show a determinate behavior. In the key study it is not seen mortality at all concentrations, in the study tested in 1990 the mortality begin at concentration equal to 7943 mg/kg b.w and the 100 % of mortality was seen at 12590 mg/kg b.w. This curve dose/response support the absence of mortality seen in the key study. For cautelative manner the LD50 = 2232 mg/kg b.w it could be used for assessment of acute administration by oral route.
Acute inhalation toxicity:
The substance tested for acute toxicity by inhalation route does not show signs of toxicity , only abnormal respiration immediately after the acute dose administration. After the next two hours and since the end of post exposure period, no signs of toxicity were observed. The value of lethal concentration used in the experiment is 2.34 mg/l (2.10 mg/l based on active ingredient), it is below the trigger value for classification (5 mg/l), but no signs of mortality were observed during the experiment, therefore the value of 2.34 mg/l is not valid as LC50.
Acute dermal toxicity
The test substance administered by dermal route shows signs of toxicity as erythema and oedema to all tested animals. After 7 days of observation period all animals return to initial conditions and remain so throughout the study. No animals die during the acute administration of 2700 mg/kg bw and during the observation period.
Justification for classification or non-classification
According to the CLP Regulation (EC n. 1272/2008) the acute toxicity is:
acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.
After the oral administration the LD50 of test item is 2232 mg/kg b.w (based on active ingredient), .
After acute dermal and inhalation administration no lethal dose (LD50 or LC50) has been derived. Taking into account that no effect at all has been reported at 2.10 mg/L for inhalation , and 2700 mg/kg for dermal it can be assumed that :
No classification for acute oral toxicity is warranted under Regulation 1272/2008
No classification for acute inhalation toxicity is warranted under Regulation 1272/2008
No classification for acute dermal toxicity is warranted under Regulation 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.